Biden and Sanders want Novo Nordisk and Eli Lilly to cut Ozempic and other weight loss drug pricesByBruce GilUpdatedJuly 2, 2024
Eli Lilly is one step closer to gaining access to one of the world's largest weight loss marketsByBruce GilPublishedJuly 1, 2024
A group of cancer victims couldn't block Johnson & Johnson's $6.5 billion talc-powder settlementByBruce GilUpdatedJuly 1, 2024
The Supreme Court just blocked Purdue Pharma's OxyContin settlement that protects the Sackler familyByBruce GilPublishedJune 27, 2024
Novo Nordisk will restrict Wegovy sales in China amid a weight loss drug shortageByBruce GilUpdatedJune 27, 2024
The FDA has issued a nationwide recall hitting over 140 canned coffee brandsByBruce GilPublishedJune 26, 2024
The Biden administration is lowering the price of 64 prescription drugs with inflation rebatesByBruce GilUpdatedJune 26, 2024
Now playing Ozempic maker Novo Nordisk just got access to one of the world's largest weight loss marketsByBruce GilPublishedJune 25, 2024
The Ozempic boom has Americans eating a lot more yogurt, Danone executive saysByBruce GilUpdatedJune 24, 2024
Wegovy helped women lose more weight than men with the same heart condition, study saysByBruce GilPublishedJune 24, 2024
New weight loss drugs, old marketing: Gyms and stores revive classic diet schemes for the Ozempic eraByBruce GilPublishedJune 24, 2024
An Ozempic alternative helps people lose weight without as many side effects, study saysByBruce GilUpdatedJune 21, 2024
Fake weight loss drugs, and Novo Nordisk's CEO will face Bernie Sanders: Pharma news roundupByBruce GilPublishedJune 21, 2024
Gilead says its HIV prevention shot was 100% effective in a clinical trialByBruce GilUpdatedJune 20, 2024
